Stivarga (regorafenib tablets - Bayer) — Cigna
Soft Tissue Sarcoma
Initial criteria
- Patient age ≥ 18 years
- Patient has advanced or metastatic disease
- Patient has ONE of the following: non-adipocytic sarcoma; pleomorphic rhabdomyosarcoma; angiosarcoma
Approval duration
1 year